health π¬ Low-cost blood test could spot cancer and liver issues
Researchers at UCLA have developed a blood test called MethylScan to detect various cancers and liver diseases. The test analyzes tiny DNA pieces circulating in the bloodstream, identifying patterns from organs. In an early study of 1,061 people, it found about 63% of cancers overall, with high success in high-risk liver patients. This technique is less invasive and potentially cheaper than current methods. Further large-scale clinical trials are required to validate its real-world screening accuracy.